After the chaos of 2020 and 2021, 2022 showed hints of a return to normalcy. But what might 2023 bring? Executives from Edwards, Medtronic, Qiagen and more shared their predictions for the year ahead.
Peter Arduini
Outlook 2023: Firms Prepare For 'World Where Health Care Has No Limits'
What's ahead for device companies in 2023? In this year-end special feature, execs at top device companies and other stakeholders share what they expect.
More from Business
More from Medtech Insight
• By
In this week's Digital Health Roundup, Medtech Insight's team discusses progress on autonomous surgery, Medtronic's new partnership with IRCAD, FDA cybersecurity news, and C-suite interviews with OpenWater, Flow Neuroscience and EnsoData.
• By
A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.
• By
US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the